Franklin Genomic Advancements ETF Rating $26.99 -0.14 (-0.51%) Closing price 04/25/2025Extended Trading$26.89 -0.10 (-0.36%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.76Holdings in HELX have an aggregate rating of Moderate Buy based on 656 analyst ratings issued in the past year covering 45 companies (84.5% of the portfolio).HELX Aggregate Price Target$26.99High Prediction$26.99Average Prediction$26.99Low Prediction$26.99Holdings in HELX have an aggregate price target of $26.99 and a range of $26.99 to $26.99 covering 45 companies (84.5% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.57%NTRANatera$153.79-0.4%2.8724 of 5 stars3.00$175.76 14.3%16Positive News5.23%KRYSKrystal Biotech$168.06-0.6%4.9049 of 5 stars3.00$220.00 30.9%8News CoveragePositive News5.14%VRTXVertex Pharmaceuticals$493.84+0.3%3.9236 of 5 stars2.64$514.91 4.3%25Upcoming EarningsAnalyst RevisionPositive News3.73%REGNRegeneron Pharmaceuticals$602.64+0.5%4.8219 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst Forecast3.60%MEDPMedpace$298.55-1.4%4.3475 of 5 stars2.23$349.30 17.0%13Earnings ReportShort Interest ↑Analyst RevisionGap Down3.44%LLYEli Lilly and Company$884.94+2.9%4.9177 of 5 stars2.89$1,017.00 14.9%19Upcoming EarningsAnalyst DowngradeAnalyst Revision3.26%TMOThermo Fisher Scientific$424.02-0.6%4.8134 of 5 stars2.81$616.95 45.5%21Earnings ReportAnalyst DowngradeShort Interest ↑Analyst Revision3.10%AZNAstraZeneca$69.57+0.0%3.6236 of 5 stars3.10$88.00 26.5%10Upcoming EarningsShort Interest ↓Positive News2.88%CTVACorteva$61.50-0.3%4.4751 of 5 stars2.72$68.13 10.8%18Upcoming EarningsPositive News2.75%ALNYAlnylam Pharmaceuticals$251.56+3.7%4.6531 of 5 stars2.77$315.58 25.5%26Upcoming EarningsPositive News2.67%UTHRUnited Therapeutics$291.38-1.7%4.8937 of 5 stars2.67$390.17 33.9%12Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Down2.60%BNTXBioNTech$102.02-15.4%2.3732 of 5 stars2.89$143.44 40.6%18Upcoming EarningsHigh Trading Volume2.54%INSMInsmed$69.69+1.1%4.2558 of 5 stars3.00$94.00 34.9%16Positive NewsHigh Trading Volume2.11%TWSTTwist Bioscience$40.11-0.1%3.5915 of 5 stars2.70$52.80 31.6%10Upcoming EarningsPositive News2.04%GHGuardant Health$48.30+1.9%3.9403 of 5 stars3.05$49.00 1.4%21Upcoming Earnings1.98%DHRDanaher$197.37+0.4%4.895 of 5 stars2.80$264.40 34.0%20Earnings ReportShort Interest ↑Analyst Revision1.97%RVTYRevvity$94.30-0.9%3.9538 of 5 stars2.77$130.50 38.4%13Dividend Announcement1.94%CDNSCadence Design Systems$289.63+2.8%4.6656 of 5 stars2.77$321.00 10.8%13Positive News1.93%RAREUltragenyx Pharmaceutical$38.09+1.2%4.3264 of 5 stars2.93$92.79 143.6%14Upcoming EarningsShort Interest ↑Positive News1.65%BBIOBridgeBio Pharma$36.31+1.0%4.5394 of 5 stars2.92$53.00 46.0%12Upcoming EarningsGap Down1.61%EXASExact Sciences$45.46-0.3%4.385 of 5 stars2.95$69.25 52.3%22Upcoming Earnings1.57%QGENQiagen$42.10-2.2%3.6441 of 5 stars2.27$47.83 13.6%11Analyst Revision1.53%LGNDLigand Pharmaceuticals$108.07-0.4%4.3828 of 5 stars3.00$146.43 35.5%7Positive News1.29%CRLCharles River Laboratories International$114.71-0.9%4.7882 of 5 stars1.94$182.00 58.7%16Gap Down1.28%AAgilent Technologies$106.31-0.7%4.7142 of 5 stars2.46$143.00 34.5%13Positive News1.28%LHLaboratory Co. of America$228.60+0.0%4.7151 of 5 stars2.87$268.77 17.6%15Upcoming EarningsShort Interest ↑Positive News1.25%BMRNBioMarin Pharmaceutical$63.30+0.9%4.9164 of 5 stars2.70$93.14 47.1%23Upcoming EarningsAnalyst UpgradePositive News1.23%RGENRepligen$144.75-0.3%4.6763 of 5 stars2.57$176.82 22.2%14Upcoming EarningsPositive News1.10%ADPTAdaptive Biotechnologies$7.90+0.1%3.4322 of 5 stars3.00$9.40 19.0%5Upcoming EarningsPositive News1.06%TEMTempus AI$52.90-1.1%2.1728 of 5 stars2.54$61.08 15.5%131.00%NBIXNeurocrine Biosciences$106.73+0.9%4.8567 of 5 stars2.86$161.14 51.0%22Upcoming EarningsAnalyst Revision0.99%IQVIQVIA$150.38-0.2%4.9283 of 5 stars2.75$237.62 58.0%24Analyst DowngradeGap Down0.87%TECHBio-Techne$50.24-1.1%4.8163 of 5 stars2.38$81.14 61.5%8Upcoming Earnings0.84%DVAXDynavax Technologies$10.82-0.7%4.2724 of 5 stars2.33$20.50 89.5%30.84%DOCSDoximity$56.67+0.7%3.2158 of 5 stars2.57$65.39 15.4%21Positive News0.76%VCYTVeracyte$32.23+0.3%3.9411 of 5 stars2.70$42.60 32.2%10Short Interest ↑0.76%RXRXRecursion Pharmaceuticals$5.73-0.3%2.2303 of 5 stars2.33$8.20 43.1%6Gap Down0.75%AZTAAzenta$26.73-1.5%3.4842 of 5 stars2.50$57.00 113.2%4Positive News0.73%SRPTSarepta Therapeutics$60.44-2.1%4.6666 of 5 stars2.83$158.70 162.6%240.71%BEAMBeam Therapeutics$19.52-3.2%3.0234 of 5 stars3.00$49.45 153.4%14Short Interest ↑0.67%BMYBristol-Myers Squibb$47.86-1.7%4.5072 of 5 stars2.33$58.00 21.2%21Earnings ReportAnalyst ForecastAnalyst Revision0.64%BIOBio-Rad Laboratories$242.22-3.0%4.3919 of 5 stars2.60$380.20 57.0%5Upcoming EarningsShort Interest ↑Positive News0.55%BRKRBruker$39.07+0.3%4.9809 of 5 stars2.55$65.00 66.4%11Short Interest ↓Positive News0.55%CPRXCatalyst Pharmaceuticals$23.45+1.1%4.6705 of 5 stars3.13$32.29 37.7%8Positive News0.54%GRALGrail$37.20-1.3%0.7446 of 5 stars2.25$26.00 -30.1%4Positive News This page (BATS:HELX) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
